Economics of the Use of Biologics in the Treatment of Inflammatory Bowel Disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology
Reference59 articles.
1. Inflammatory bowel disease: medical cost algorithms;Hay;J Clin Gastroenterol,1992
2. Inflammatory bowel disease: costs-of-illness;Hay;J Clin Gastroenterol,1992
3. Advances in the management of Crohn's disease: economic and clinical potential of infliximab;Hanauer;Clin Ther,1998
4. Annual cost of care for Crohn's disease: a payor perspective;Feagan;Am J Gastroenterol,2000
5. The cost of hospitalizations in Crohn's disease;Cohen;Am J Gastroenterol,2000
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease;World Journal of Clinical Cases;2021-12-26
2. DISCONTINUATION RATES FOLLOWING A SWITCH FROM A REFERENCE TO A BIOSIMILAR BIOLOGIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS;Arquivos de Gastroenterologia;2020-09
3. Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database;Journal of Pharmaceutical Health Care and Sciences;2019-10-07
4. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy;Inflammatory Bowel Diseases;2018-08-18
5. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function;Inflammopharmacology;2017-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3